RECORDATI |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.6 USD | -0.73% |
|
-.--% | +12.17% |
| 06-25 | Recordati acquires its own shares for approximately EUR3 million | AN |
| 06-18 | Recordati acquires treasury shares for more than EUR4 million | AN |
Chart calendar Recordati
f604239cf632cb731edf6bb.FpHhIzw3hM1KcDq8Y8Y_ngj9sZfdWTfRFXijbcbPcAE.RvynfA918okCSE7oV6FZx0C48siIOnWQdEzMOqP7B29029FAem7K_RwdUQ~f614ad34c79e92e46ddc2bf0313d2f3a
Upcoming events on Recordati
Past events on Recordati
| 24/06/2024 | Stifel European Healthcare Summit |
| 19/06/2024 | JP Morgan European Healthcare Conference |
| 18/06/2024 | Mediobanca Italian CEO Conference |
| 09/06/2024 | Goldman Sachs Global Healthcare Conference |
| 05/06/2024 | Jefferies Global Healthcare Conference |
| 28/05/2024 | Non Deal Roadshow |
| 22/05/2024 | Unicredit/Kepler Italian Investment Conference |
| 19/05/2024 | Final dividend |
| 09/05/2024 15:00 | Q1 2024 Earnings Call |
| 09/05/2024 12:03 | Q1 2024 Earnings Release |
| 11/03/2024 | Barclays Global Healthcare Conference |
| 26/02/2024 | UBS European Healthcare Conference |
| 22/02/2024 15:00 | Q4 2023 Earnings Call |
| 22/02/2024 11:45 | Q4 2023 Earnings Release |
| 09/01/2024 | J.P. Morgan Healthcare Conference |
| 19/11/2023 | Détachement de for dividende intermédiaire |
| 13/11/2023 | Jefferies London Healthcare Conference |
| 08/11/2023 | Roadshow - Deutsche Bank |
| 07/11/2023 | Roadshow - Jefferies |
| 07/11/2023 15:00 | Q3 2023 Earnings Call |
Past dividends on Recordati
| 19/05/2024 | Final Payment 0.63 EUR |
| 19/11/2023 | Interim Payment 0.57 EUR |
| 21/05/2023 | Final Payment 0.6 EUR |
| 20/11/2022 | Interim Payment 0.55 EUR |
| 22/05/2022 | Final Payment 0.57 EUR |
| 21/11/2021 | Interim Payment 0.53 EUR |
| 23/05/2021 | Final Payment 0.55 EUR |
| 22/11/2020 | Interim Payment 0.5 EUR |
| 17/05/2020 | Final Payment 0.52 EUR |
| 17/11/2019 | Interim Payment 0.48 EUR |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 1 482 1 472 0.67% | 1 449 1 468 -1.29% | 1 580 1 579 0.07% | 1 853 1 852 0.06% | 2 082 2 083 -0.02% | 2 301 |
|
EBITDA Million EUR | Released Forecast Spread | 544 544 0.06% | 569 579 -1.6% | 602 603 -0.12% | 673 659 2.14% | 770 769 0.07% | 845 |
|
EBIT Million EUR | Released Forecast Spread | 465 468 -0.52% | 469 483 -2.95% | 490 507 -3.36% | 437 496 -11.76% | 558 597 -6.55% | 685 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 444 446 -0.38% | 456 463 -1.49% | 463 477 -2.86% | 401 410 -2.01% | 491 495 -0.88% | 586 |
|
Net income Million EUR | Released Forecast Spread | 369 332 10.97% | 355 372 -4.58% | 386 405 -4.76% | 312 367 -14.97% | 389 399 -2.56% | 474 |
|
EPS EUR | Released Forecast Spread | 1,76 1,59 10.94% | 1,70 1,75 -2.94% | 1,85 1,91 -3.54% | 1,49 1,59 -6.07% | 1,86 1,87 -0.39% | 2,22 |
| Announcement Date | 14/02/20 | 22/02/21 | 24/02/22 | 21/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 S1 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 760 780 -2.48% | 771 764 0.88% | 419 412 1.78% | 473 449 5.26% | 892 865 3.21% | 485 450 7.7% | 476 474 0.4% | 551 551 -0.02% | 493 494 -0.26% | 1 044 1 046 -0.12% | 512 512 0.01% | 526 530 -0.77% | |
|
EBITDA Million EUR | Released Forecast Spread | 311 306 1.68% | 301 296 1.55% | 163 155 5.47% | 172 169 1.76% | 335 333 0.7% | 181 162 11.97% | 157 152 3.26% | 221 206 7.21% | 185 177 5.04% | 406 386 5.36% | 189 184 2.88% | 174 177 -1.57% | 244 242 1.01% |
|
EBIT Million EUR | Released Forecast Spread | 262 261 0.27% | 250 249 0.5% | 131 127 3.74% | 101 131 -23.08% | 232 271 -14.21% | 124 108 14.74% | 81,4 115 -28.99% | 173 162 6.5% | 166 140 17.97% | 338 329 2.67% | 101 146 -31.03% | 119 118 1.1% | |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 254 252 0.86% | 236 235 0.06% | 124 119 4.38% | 69,8 99,3 -29.66% | 194 219 -11.29% | 116 91,0 27% | 91,7 88,9 3.14% | 160 145 10.38% | 129 115 12.23% | 289 276 4.83% | 101 113 -10.48% | 101 93,8 8% | 172 |
|
Net income Million EUR | Released Forecast Spread | 197 195 1.1% | 207 195 5.99% | 96,7 91,5 5.7% | 54,7 76,8 -28.75% | 151 170 -11.04% | 90,1 74,2 21.37% | 70,8 87,7 -19.22% | 124 113 10.18% | 104 89,3 16.02% | 228 215 5.84% | 76,9 88,9 -13.5% | 84,7 70,3 20.54% | 124 132 -6.37% |
|
EPS EUR | Released Forecast Spread | 0,94 0,94 0.21% | 0,99 | 0,46 0,50 -6.67% | 0,26 0,42 -37.62% | 0,43 0,34 26.76% | 0,34 0,35 -1.74% | 0,59 0,60 -0.34% | 0,50 0,41 20.73% | 0,37 0,45 -18.22% | 0,34 | 0,59 0,63 -6.19% | ||
| Announcement Date | 30/07/20 | 29/07/21 | 10/05/22 | 28/07/22 | 28/07/22 | 08/11/22 | 21/02/23 | 11/05/23 | 28/07/23 | 28/07/23 | 07/11/23 | 22/02/24 | 09/05/24 |
More events
Past sector events for Recordati
| 21/06/2024 16:28 | DEVA HOLDING: Q1 2024 Earnings Release |
| 13/06/2024 22:21 | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 11/06/2024 06:30 | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 07/06/2024 11:33 | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 07/06/2024 10:17 | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 30/05/2024 13:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 30/05/2024 12:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 30/05/2024 07:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 13:00 | FDC LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 10:26 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- REC Stock
- RCDTF Stock
- Calendar Recordati
